Your browser doesn't support javascript.
loading
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries.
Malaty, Irene A; Martinez-Martin, Pablo; Chaudhuri, K Ray; Odin, Per; Skorvanek, Matej; Jimenez-Shahed, Joohi; Soileau, Michael J; Lindvall, Susanna; Domingos, Josefa; Jones, Sarah; Alobaidi, Ali; Jalundhwala, Yash J; Kandukuri, Prasanna L; Onuk, Koray; Bergmann, Lars; Femia, Samira; Lee, Michelle Y; Wright, Jack; Antonini, Angelo.
Afiliação
  • Malaty IA; University of Florida, Fixel Institute for Neurological Diseases, Gainesville, FL, USA. Irene.malaty@neurology.ufl.edu.
  • Martinez-Martin P; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain.
  • Chaudhuri KR; Parkinson Foundation Centre of Excellence, King's College Hospital and King's College, London, UK.
  • Odin P; University of Lund, Lund, Sweden.
  • Skorvanek M; Department of Neurology, P. J. Safárik University, Kosice, Slovakia.
  • Jimenez-Shahed J; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovakia.
  • Soileau MJ; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lindvall S; Texas Movement Disorder Specialists, Georgetown, TX, USA.
  • Domingos J; European Parkinson's Disease Association (EPDA), Sevenoaks, UK.
  • Jones S; European Parkinson's Disease Association (EPDA), Sevenoaks, UK.
  • Alobaidi A; Grupo de patologia médica, nutrição e exercício clínico (PaMNEC) do CiiEM, Almada, Portugal.
  • Jalundhwala YJ; Parkinson & Movement Disorder Alliance, Tucson, USA.
  • Kandukuri PL; AbbVie Inc., North Chicago, IL, USA.
  • Onuk K; University of Illinois at Chicago, Chicago, IL, USA.
  • Bergmann L; AbbVie Inc., North Chicago, IL, USA.
  • Femia S; AbbVie Inc., North Chicago, IL, USA.
  • Lee MY; AbbVie Inc., North Chicago, IL, USA.
  • Wright J; AbbVie Inc., North Chicago, IL, USA.
  • Antonini A; AbbVie Inc., North Chicago, IL, USA.
BMC Neurol ; 22(1): 35, 2022 Jan 24.
Article em En | MEDLINE | ID: mdl-35073872
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article